October 5


How Did an Epigenetic Startup Develop One of the World’s First Saliva Tests for COVID? | SOSV

By heheals

October 5, 2020

CEO Dr. Tom Stubbs talks about Chronomics’ genesis as an epigenetic testing company and their rapid development of an accurate, CE marked, RT-PCR saliva testing kit for the identification of COVID-19 infection.

Also discussed: the amazing power of epigenetics to identify health risks and point to potential solutions that are under our control. More important now than ever before…

00:39 Stubbs: “Somebody that’s at high risk for heart disease versus somebody at low risk from a genetic predisposition perspective could be fourfold more likely to suffer from heart disease, which sounds pretty bad. But when you put that into the context of environment and lifestyle-derived risk, it’s actually 5,000 fold. So there’s a huge amount more risk that can be explained by things that are actually under our control and can be measured using biomarkers derived, for instance, from epigenetics…”

More Information: https://www.chronomics.com
More about SOSV: http://www.sosv.com

► Subscribe for more content from SOSV: https://bit.ly/2AXgcLk
► Learn the language of Venture Capital with VC Lingo at: https://goo.gl/vHB7kP
► More insights into top Venture Capital firms from the VCs that run them via 42 Questions: https://bit.ly/2lIfZYs


SOSV is a multi-stage venture capital investor. We run multiple world-class vertical accelerator programs, and provide seed, venture and growth stage follow-on investment into superstar companies. Our unique full-stack model has delivered a net IRR over the last 20 years that puts us in the top 10% of all venture funds worldwide.

SOSV provides intellectual and financial capital to accelerate founders’ big ideas for positive change. SOSV has funded over 900 startups to date. We currently fund over 150 startups per year through our programs: HAX (hardware and connected devices), IndieBio (life sciences), Chinaccelerator and MOX (cross-border internet and mobile in Asia), dlab (blockchain, data and decentralization), and Food-X (food innovation).

We pledge more than funds. We provide the seed capital to get founders moving, a global staff of hands-on engineers, designers, accountants, and scientists to accelerate product development, over 1,000 global mentors with deep market and technical expertise, and an unparalleled network of fully outfitted laboratory and maker spaces to help startups go further, faster.

Building a better future means empowering the next generation of entrepreneurs and scientists to solve the biggest challenges that our world is facing today: addressing global health, sustainable food systems, advanced manufacturing, connectivity in the developing world, and beyond. Nearly half of our portfolio companies directly align to the UN’s sustainable development goals and SOSV is proud to be a top investor for female founded companies.

Are you a potential market champion that is pioneering new ground, or an investor looking to help scale the companies that will shape our future? Join one of our accelerators or learn about investing in SOSV, and let’s work together to make the impossible inevitable.

For more info on SOSV: http://www.sosv.com
To apply to one of our accelerators: http://www.sosv.com/accelerators



About the author

Leave a Repl​​​​​y

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}

Never miss a good story!

 Subscribe to our newsletter to keep up with the latest trends!